Technical Analysis for AFP - AFT Pharmaceuticals Ltd
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 2.790 | -3.13% | -0.090 |
Earnings due: Nov 21
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| MACD Bearish Centerline Cross | Bearish | 0.00% | |
| Expansion Breakdown | Bearish Swing Setup | 0.00% | |
| Hammer Candlestick | Bullish | 0.00% | |
| Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Fell Below 50 DMA | Bearish | -3.13% | |
| Narrow Range Bar | Range Contraction | -3.13% |
| Alert | Time |
|---|---|
| Down 10% | 1 day ago |
| Down 2 ATRs | 1 day ago |
| Down 1 ATR | 1 day ago |
| Down 5% | 1 day ago |
| Down 3% | 1 day ago |
Get this analysis on your stocks daily!
AFT Pharmaceuticals Ltd Description
AFT Pharmaceuticals Limited is a pharmaceutical distributor and developer of pharmaceutical intellectual property. The Company's segments include New Zealand, Australia, Asia and Rest of World. The Company's products include Crystaderm, Maxigesic, Coco-scalp, Maxiclear, RestoraNail and Myconail, among others. The Company's NasoSURF Nebuliser is in pilot scale production. The Company is focused on conducting clinical for Maxigesic oral dose forms. The Company is also conducting clinical trials of Maxigesic intravenous (IV). Maxigesic PE is a cold and flu variant. Its subsidiary, AFT Pharmaceuticals (AU) Pty Ltd, is engaged in distribution of pharmaceuticals in Australia. Its subsidiary, AFT Pharmaceuticals Singapore Pte Ltd, is engaged in the registration of pharmaceuticals in Singapore. Its subsidiary, AFT Pharmaceuticals (S.E. Asia) Sdn Bhd, is engaged in the distribution of pharmaceuticals in Malaysia.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Health Pharmaceutical Flu Pharmaceuticals Clinical Trial Intellectual Property Ducting Pharmaceuticals Policy Pharmaceutical Industry In China Science And Technology In The People's Republic Of China
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.6688 |
| 52 Week Low | 2.4174 |
| Average Volume | 2,436 |
| 200-Day Moving Average | 3.075 |
| 50-Day Moving Average | 2.920 |
| 20-Day Moving Average | 2.966 |
| 10-Day Moving Average | 2.921 |
| Average True Range | 0.080 |
| RSI (14) | 40.83 |
| ADX | 13.52 |
| +DI | 27.399 |
| -DI | 64.783 |
| Chandelier Exit (Long, 3 ATRs) | 2.919 |
| Chandelier Exit (Short, 3 ATRs) | 2.831 |
| Upper Bollinger Bands | 3.163 |
| Lower Bollinger Band | 2.769 |
| Percent B (%b) | 0.05 |
| BandWidth | 13.277 |
| MACD Line | -0.010 |
| MACD Signal Line | 0.008 |
| MACD Histogram | -0.0173 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.135 | ||||
| Resistance 3 (R3) | 3.107 | 2.963 | 3.078 | ||
| Resistance 2 (R2) | 2.963 | 2.875 | 2.978 | 3.058 | |
| Resistance 1 (R1) | 2.877 | 2.821 | 2.805 | 2.905 | 3.039 |
| Pivot Point | 2.733 | 2.733 | 2.698 | 2.748 | 2.733 |
| Support 1 (S1) | 2.647 | 2.645 | 2.575 | 2.675 | 2.541 |
| Support 2 (S2) | 2.503 | 2.591 | 2.518 | 2.522 | |
| Support 3 (S3) | 2.417 | 2.503 | 2.503 | ||
| Support 4 (S4) | 2.445 |
